HUE047062T2 - Angiotenzin II alacsony vérnyomás kombinációs kezelésére - Google Patents

Angiotenzin II alacsony vérnyomás kombinációs kezelésére

Info

Publication number: HUE047062T2
Authority: HU; Hungary
Prior art keywords: hypotension; angiotensin; treatment; combination
Prior art date: 2013-12-18

Application number

HUE14872684A

Other languages

English (en)

Inventor

Lakhmir Chawla

Original Assignee

The George Washington Univ A Congressionally Chartered Not For Profit Corporation

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2013-12-18

Filing date

2014-12-18

Publication date

2020-04-28

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=53367119&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUE047062(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2014-12-18 Application filed by The George Washington Univ A Congressionally Chartered Not For Profit Corporation filed Critical The George Washington Univ A Congressionally Chartered Not For Profit Corporation

2020-04-28 Publication of HUE047062T2 publication Critical patent/HUE047062T2/hu

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/085—Angiotensins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Immunology (AREA)
Vascular Medicine (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Emergency Medicine (AREA)
Dermatology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Peptides Or Proteins (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

HUE14872684A 2013-12-18 2014-12-18 Angiotenzin II alacsony vérnyomás kombinációs kezelésére HUE047062T2 (hu)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US201361917576P	2013-12-18	2013-12-18
US201461955706P	2014-03-19	2014-03-19

Publications (1)

Publication Number	Publication Date
HUE047062T2 true HUE047062T2 (hu)	2020-04-28

Family

ID=53367119

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HUE14872684A HUE047062T2 (hu)	2013-12-18	2014-12-18	Angiotenzin II alacsony vérnyomás kombinációs kezelésére

Country Status (23)

Country	Link
US (7)	US9220745B2 (hu)
EP (2)	EP2986308B1 (hu)
JP (3)	JP6824739B2 (hu)
KR (3)	KR20220028125A (hu)
CN (3)	CN112546197A (hu)
AU (2)	AU2014364528C1 (hu)
BR (1)	BR112016013961A2 (hu)
CA (1)	CA2933601A1 (hu)
CY (1)	CY1122604T1 (hu)
DK (1)	DK2986308T3 (hu)
EA (1)	EA037823B1 (hu)
ES (1)	ES2771749T3 (hu)
HR (1)	HRP20200009T1 (hu)
HU (1)	HUE047062T2 (hu)
IL (1)	IL246162B (hu)
LT (1)	LT2986308T (hu)
MX (2)	MX2016008108A (hu)
NZ (1)	NZ721089A (hu)
PL (1)	PL2986308T3 (hu)
PT (1)	PT2986308T (hu)
RS (1)	RS59804B1 (hu)
SI (1)	SI2986308T1 (hu)
WO (1)	WO2015095535A1 (hu)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US9572856B2 (en)	2009-12-16	2017-02-21	The George Washington University a Congressionally Chartered Not-for-Profit Corporation	Method of treating low blood pressure
CN112546197A (zh)	2013-12-18	2021-03-26	乔治华盛顿大学国会特许非营利公司	血管紧张素ii单独或以组合方式用于治疗低血压
MX2017000306A (es) *	2014-07-08	2017-07-10	La Jolla Pharma Co	Metodos para tratar hipotension.
WO2016153558A1 (en)	2015-03-20	2016-09-29	Atkinson Arthur J	Use of angiotensin ii (aii) receptor agonists to prevent or reduce hemodialysis-associated skeletal muscle cramps
EP3400001A1 (en) *	2016-01-07	2018-11-14	La Jolla Pharmaceutical Company	Methods of administering vasopressors
EP3400000B1 (en)	2016-01-07	2023-12-06	La Jolla Pharma, LLC	Methods for administering angiotensin ii
US11583568B2 (en)	2017-04-14	2023-02-21	La Jolla Pharma, Llc	Methods for administering angiotensin II
TW201927331A (zh) *	2017-12-15	2019-07-16	美商拉荷亞製藥公司	血管收縮素組合物及與其相關之方法
WO2023244552A1 (en) *	2022-06-15	2023-12-21	Virginia Commonwealth University	Methods for fluid resuscitation of an organ donor
WO2024129057A1 (en) *	2022-12-12	2024-06-20	Proletariat Therapeutics, Inc.	Methods of treating cardiac injury

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HU181008B (en)	1980-01-18	1983-05-30	Richter Gedeon Vegyeszet	Process for producing angiotenzin-ii analogues of antagonistic activity containing sarcosyl-group at the 1-positon,and an alpha-hydroxy-carboxylic acid at the 8-position
US5216025A (en)	1989-09-13	1993-06-01	Board Of Regents, The University Of Texas System	Nitric oxide synthesis inhibitors for potentiating the action of pressor agents in certain hypotensive patients
US5444067A (en)	1993-08-30	1995-08-22	Merck & Co., Inc.	Pharmaceutical treatment methods using angiotensin II receptor agonists bearing a thiophene moiety
CA2448051A1 (en)	2001-06-04	2002-12-12	Human Genome Sciences, Inc.	Methods and compositions for modulating ace-2 activity
US7115266B2 (en)	2001-10-05	2006-10-03	Cytos Biotechnology Ag	Angiotensin peptide-carrier conjugates and uses thereof
JP2007510643A (ja)	2003-11-06	2007-04-26	ジーイー・ヘルスケア・アクスイェ・セルスカプ	医薬化合物
NO20034952D0 (no)	2003-11-06	2003-11-06	Amersham Health As	Farmasöytiske forbindelser
FR2880807B1 (fr) *	2005-01-19	2007-04-13	Aguettant Sa Lab	Composition pharmaceutique injectable
JP2009510056A (ja)	2005-09-29	2009-03-12	ファイブローゲン、インコーポレーテッド	血圧を低下させる方法
EP1971358A4 (en) *	2005-12-30	2010-05-26	Florey Howard Inst	Methods of Treatment
US20070293552A1 (en)	2006-06-15	2007-12-20	Gorczynski Richard J	Antihypertensive therapy method
WO2008130217A1 (en) *	2006-08-08	2008-10-30	Applied Nanosystems B.V.	Cyclic angiotensin analogs
JP2010510196A (ja)	2006-11-17	2010-04-02	ダ・ボルテラ	オイドラギット被覆を施した亜鉛／ペクチンビーズを使用する結腸送達
WO2009009907A1 (en) *	2007-07-18	2009-01-22	The University Of British Columbia	Use of vasopressin-receptor agonists for the treatment of septic shock
EP2161030A1 (en) *	2008-09-09	2010-03-10	Rijksuniversiteit te Groningen	Oxytocin formulations and uses thereof
RU2011126338A (ru)	2008-11-28	2013-01-10	Эбботт Лэборетриз	Стабильные композиции антител и способы их стабилизации
US9572856B2 (en)	2009-12-16	2017-02-21	The George Washington University a Congressionally Chartered Not-for-Profit Corporation	Method of treating low blood pressure
FR2959414B1 (fr) *	2010-04-30	2016-01-08	Luc Quintin	Combinaison de molecules aux fins de traitement d'hypotension survenant au cours du choc septique, cardiogenique, ou anaphylactique refractaire, ou hemorragique terminal, apres correction de la volemie et de l'etat de mal asthmatique refractaire
BR112013000744A2 (pt)	2010-07-14	2020-07-14	Cumberland Emerging Technologies, Inc	uso de um antagonista de receptor de tromboxana a2 para prevenção ou tratamento de síndrome hepatorrenal,encefalopatia hepática,e doenças associadas
CN105592855A (zh)	2013-04-26	2016-05-18	拉卓拉药物公司	用于治疗肾衰竭的组合物和方法
CN112546197A (zh)	2013-12-18	2021-03-26	乔治华盛顿大学国会特许非营利公司	血管紧张素ii单独或以组合方式用于治疗低血压
US20150286797A1 (en)	2014-04-02	2015-10-08	David R. Ratto	System and method for administering medication
MX2017000306A (es)	2014-07-08	2017-07-10	La Jolla Pharma Co	Metodos para tratar hipotension.
EP3400001A1 (en)	2016-01-07	2018-11-14	La Jolla Pharmaceutical Company	Methods of administering vasopressors
EP3400000B1 (en)	2016-01-07	2023-12-06	La Jolla Pharma, LLC	Methods for administering angiotensin ii
US11583568B2 (en)	2017-04-14	2023-02-21	La Jolla Pharma, Llc	Methods for administering angiotensin II
TW201927331A (zh)	2017-12-15	2019-07-16	美商拉荷亞製藥公司	血管收縮素組合物及與其相關之方法

2014
- 2014-12-18 CN CN202011494632.XA patent/CN112546197A/zh active Pending
- 2014-12-18 US US14/575,127 patent/US9220745B2/en active Active
- 2014-12-18 PT PT148726847T patent/PT2986308T/pt unknown
- 2014-12-18 EP EP14872684.7A patent/EP2986308B1/en active Active
- 2014-12-18 AU AU2014364528A patent/AU2014364528C1/en active Active
- 2014-12-18 JP JP2016539318A patent/JP6824739B2/ja active Active
- 2014-12-18 RS RS20200021A patent/RS59804B1/sr unknown
- 2014-12-18 HU HUE14872684A patent/HUE047062T2/hu unknown
- 2014-12-18 CN CN201480075899.1A patent/CN106061493A/zh active Pending
- 2014-12-18 DK DK14872684.7T patent/DK2986308T3/da active
- 2014-12-18 EA EA201691258A patent/EA037823B1/ru unknown
- 2014-12-18 KR KR1020227004084A patent/KR20220028125A/ko active Application Filing
- 2014-12-18 MX MX2016008108A patent/MX2016008108A/es unknown
- 2014-12-18 BR BR112016013961A patent/BR112016013961A2/pt not_active Application Discontinuation
- 2014-12-18 SI SI201431450T patent/SI2986308T1/sl unknown
- 2014-12-18 ES ES14872684T patent/ES2771749T3/es active Active
- 2014-12-18 CN CN202010824424.5A patent/CN111920939A/zh active Pending
- 2014-12-18 KR KR1020237012136A patent/KR20230051721A/ko not_active Application Discontinuation
- 2014-12-18 EP EP19197866.7A patent/EP3607962A1/en active Pending
- 2014-12-18 NZ NZ721089A patent/NZ721089A/en unknown
- 2014-12-18 WO PCT/US2014/071186 patent/WO2015095535A1/en active Application Filing
- 2014-12-18 PL PL14872684T patent/PL2986308T3/pl unknown
- 2014-12-18 LT LTEP14872684.7T patent/LT2986308T/lt unknown
- 2014-12-18 KR KR1020167019427A patent/KR102399383B1/ko active IP Right Grant
- 2014-12-18 CA CA2933601A patent/CA2933601A1/en active Pending
2015
- 2015-11-13 US US14/941,301 patent/US10028995B2/en active Active
2016
- 2016-06-09 IL IL246162A patent/IL246162B/en active IP Right Grant
- 2016-06-17 MX MX2020011190A patent/MX2020011190A/es unknown
2018
- 2018-03-01 US US15/909,617 patent/US10493124B2/en active Active
- 2018-09-19 US US16/135,608 patent/US10765722B2/en active Active
2019
- 2019-04-12 US US16/382,850 patent/US11096983B2/en active Active
- 2019-08-23 JP JP2019153144A patent/JP7175506B2/ja active Active
2020
- 2020-01-03 HR HRP20200009TT patent/HRP20200009T1/hr unknown
- 2020-01-13 CY CY20201100026T patent/CY1122604T1/el unknown
- 2020-11-26 AU AU2020277230A patent/AU2020277230A1/en active Pending
2021
- 2021-07-20 US US17/380,311 patent/US11559559B2/en active Active
2022
- 2022-07-14 JP JP2022113327A patent/JP2022137224A/ja active Pending
2023
- 2023-01-23 US US18/157,933 patent/US20230226141A1/en not_active Abandoned

Also Published As

Publication number	Publication date
JP2019214610A (ja)	2019-12-19
US10493124B2 (en)	2019-12-03
US20230226141A1 (en)	2023-07-20
MX2020011190A (es)	2020-11-13
US20190070250A1 (en)	2019-03-07
AU2014364528C1 (en)	2021-01-07
US9220745B2 (en)	2015-12-29
EA201691258A1 (ru)	2016-11-30
PL2986308T3 (pl)	2020-05-18
MX2016008108A (es)	2017-03-09
KR20220028125A (ko)	2022-03-08
BR112016013961A2 (pt)	2017-10-10
KR20230051721A (ko)	2023-04-18
RS59804B1 (sr)	2020-02-28
CY1122604T1 (el)	2021-03-12
EP3607962A1 (en)	2020-02-12
US20190328827A1 (en)	2019-10-31
DK2986308T3 (en)	2020-01-27
EP2986308B1 (en)	2019-10-16
KR102399383B1 (ko)	2022-05-19
US11559559B2 (en)	2023-01-24
EP2986308A1 (en)	2016-02-24
CN111920939A (zh)	2020-11-13
LT2986308T (lt)	2020-03-25
HRP20200009T1 (hr)	2020-03-20
US20220047669A1 (en)	2022-02-17
PT2986308T (pt)	2020-01-21
CA2933601A1 (en)	2015-06-25
AU2014364528A1 (en)	2016-06-30
ES2771749T3 (es)	2020-07-07
EP2986308A4 (en)	2017-01-11
US10765722B2 (en)	2020-09-08
CN112546197A (zh)	2021-03-26
NZ721089A (en)	2022-10-28
JP6824739B2 (ja)	2021-02-03
CN106061493A (zh)	2016-10-26
AU2014364528A9 (en)	2016-07-28
JP2022137224A (ja)	2022-09-21
IL246162B (en)	2020-03-31
US20150164980A1 (en)	2015-06-18
SI2986308T1 (sl)	2020-03-31
US20180193407A1 (en)	2018-07-12
AU2020277230A1 (en)	2020-12-24
WO2015095535A9 (en)	2016-07-14
WO2015095535A1 (en)	2015-06-25
AU2014364528B2 (en)	2020-08-27
KR20160117437A (ko)	2016-10-10
US11096983B2 (en)	2021-08-24
JP2017501154A (ja)	2017-01-12
EA037823B1 (ru)	2021-05-25
IL246162A0 (en)	2016-07-31
US20160129072A1 (en)	2016-05-12
US10028995B2 (en)	2018-07-24
JP7175506B2 (ja)	2022-11-21

Publication	Publication Date	Title
GB201321743D0 (en)	2014-01-22	Therapeutic agents
GB201321738D0 (en)	2014-01-22	Therapeutic Agents
GB201321736D0 (en)	2014-01-22	Therapeutic agents
GB201321729D0 (en)	2014-01-22	Therapeutic agents
IL246162A0 (en)	2016-07-31	Angiotensin II, alone or in combination, to treat low blood pressure
GB201321733D0 (en)	2014-01-22	Therapeutic agents
GB201321728D0 (en)	2014-01-22	Therapeutic agents
GB201321739D0 (en)	2014-01-22	Therapeutic agents
GB201321730D0 (en)	2014-01-22	Therapeutic agents
GB201321741D0 (en)	2014-01-22	Therapeutic agents
GB201321740D0 (en)	2014-01-22	Therapeutic agents
GB201321732D0 (en)	2014-01-22	Therapeutic agents
GB201321734D0 (en)	2014-01-22	Therapeutic Agents
GB201321737D0 (en)	2014-01-22	Therapeutic Agents
GB201321744D0 (en)	2014-01-22	Therapeutic agents
GB201321742D0 (en)	2014-01-22	Therapeutic agents
HK1215164A1 (zh)	2016-08-19	處理方法
GB201321735D0 (en)	2014-01-22	Therapeutic Agents
GB201321745D0 (en)	2014-01-22	Therapeutic agents
GB201304872D0 (en)	2013-05-01	Treatment
GB201321731D0 (en)	2014-01-22	Therapeutic agents
GB2516814B (en)	2016-08-31	Use of phytocannabinoids for increasing radiosensitivity in the treatment of cancer
HK1216391A1 (zh)	2016-11-11	組合治療
GB201302839D0 (en)	2013-04-03	Water Treatment
HK1209097A1 (en)	2016-03-24	Water treatment